Feb 21 (Reuters) - Lucira Health Inc LHDX.O :
* LUCIRA HEALTH INC - ON FEBRUARY 14, NOTIFIED ALL EMPLOYEES
AND
EXECUTIVE OFFICERS THAT THEIR EMPLOYMENT IS EXPECTED TO
TERMINATE ON APRIL 15, 2023
* LUCIRA HEALTH - ON FEB 14, GHAZI KASHMOLAH, CHIEF QUALITY
OFFICER AND EVP REGULATORY AFFAIRS, PROVIDED NOTICE OF HIS
DECISION TO RESIGN
* LUCIRA HEALTH INC - DOES NOT EXPECT TO INCUR MATERIAL
CHARGES IN
CONNECTION WITH ACTION
* LUCIRA HEALTH INC - MAY INCUR COSTS NOT CURRENTLY
CONTEMPLATED
DUE TO EVENTS THAT MAY OCCUR AS A RESULT OF, OR THAT ARE
ASSOCIATED WITH, ACTION
* LUCIRA HEALTH-NOTIFIED EXECUTIVE OFFICERS, INCLUDING
PRESIDENT &
CEO ERIK T. ENGELSON THAT THEIR EMPLOYMENT IS EXPECTED TO
TERMINATE ON APRIL 15, 2023
* LUCIRA HEALTH-NOTIFIED EXECUTIVE OFFICERS, INCLUDING CFO
RICHARD
NARIDO THAT THEIR EMPLOYMENT IS EXPECTED TO TERMINATE ON APRIL
15, 2023
Further company coverage: LHDX.O
((Reuters.Briefs@thomsonreuters.com;;))